Cellyan Biotechnology Co., Ltd (HKPD)
NASDAQ: HKPD · Real-Time Price · USD
0.628
-0.021 (-3.30%)
At close: Mar 9, 2026, 4:00 PM EDT
0.673
+0.045 (7.10%)
After-hours: Mar 9, 2026, 5:11 PM EDT
Cellyan Biotechnology Market Cap
Cellyan Biotechnology has a market cap or net worth of $6.91 million as of March 9, 2026. Its market cap has decreased by -64.50% in one year.
Market Cap
6.91M
Enterprise Value
6.30M
1-Year Change
-64.50%
Ranking
Category
Stock Price
$0.63
Market Cap Chart
Since the IPO on January 15, 2025, Cellyan Biotechnology's market cap has decreased from $44.00M to $6.91M, a decrease of -84.29%. That is a compound annual growth rate of -80.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 7.15M | -21.17% |
| Dec 31, 2025 | 9.07M | -79.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 884.72B |
| Johnson & Johnson | 579.34B |
| AbbVie | 406.87B |
| Novartis AG | 302.19B |
| enVVeno Medical | 7.51M |
| Addex Therapeutics | 7.49M |
| GridAI Technologies | 7.40M |
| Pulmatrix | 7.38M |